Neuroinflammation as a Predictor of Chronicity in Whiplash
Does Peripheral Neuroinflammation Predict Chronicity Following Whiplash?
1 other identifier
observational
147
1 country
2
Brief Summary
Whiplash describes an injury to the neck caused by a rapid movement of the head. It often occurs during a motor vehicle collision, causing considerable pain and distress. Most patients are diagnosed with whiplash associated disorder grade-2 (WAD2). Half of these patients develop chronic pain. Current treatments for patients are ineffective. It is difficult to predict which patients will develop chronic pain, and therefore how to manage these patients. The characteristics of pain felt by many patients with WAD2 suggests that symptoms are caused by an injury to the nerves in the neck and arm. However, on clinical examination there is no indication that these nerves are significantly injured. Work from the investigators' laboratory suggests that nerves may be inflamed. In this study, the contribution of nerve inflammation to symptoms early following whiplash will be established. It will determine whether clinical tests are able to identify those patients with inflamed nerves. It will also determine whether the presence of nerve inflammation can be used to identify patients who develop chronic pain. The study will recruit 115 patients within one month following a whiplash injury and thirty-two healthy volunteers. Participants will undergo a clinical assessment. A blood sample will be taken to look for inflammatory proteins and magnetic resonance imaging will be used to identify nerve inflammation in the neck and wrist. Questionnaires to establish neck disability, pain quality and psychological distress will be completed. MRI findings will be compared to healthy controls. At six-months, patients will be asked to repeat the questionnaires, which will be used to identify those patients who have recovered. Twenty-five recovered and twenty-five non-recovered patients will undergo a repeat MRI and clinical assessment. Although patients on this study will not directly benefit, the findings will help with early diagnosis and could refocus treatment to reduce chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedNovember 4, 2022
November 1, 2022
1.7 years
June 9, 2021
November 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
MRI T2-weighted nerve signal strength
T2-weighted nerve signal strength in the brachial plexus and median nerve compared to healthy control group
Baseline
Change in MRI T2-weighted nerve signal strength
Change in T2-weighted nerve signal strength in the brachial plexus and median nerve at 6 months compared to baseline
From baseline to 6 months
Fractional anisotropy from diffusion tensor images
Fractional anisotropy measurements from brachial plexus and median nerve compared to healthy controls
Baseline
Change in fractional anisotropy from Diffusion tensor images
Fractional anisotropy from brachial plexus and median nerve compared to baseline
From baseline to 6 months
Secondary Outcomes (18)
T1 MRI median nerve morphology
Baseline
Changes to T1 MRI median nerve morphology
From baseline to 6 months
Pro-inflammatory cytokine levels
Baseline
Change in Pro-inflammatory cytokine levels
From baseline to 6 months
Tests for heightened nerve mechanosensitivity- upper limb neurodynamic test (median nerve)
Baseline
- +13 more secondary outcomes
Study Arms (2)
Patients
Patients within 4 weeks of a whiplash injury.
Healthy controls
Age and gender matched healthy controls
Interventions
T2 weighted and DTI MRI images of brachial plexus and wrist. Quantitative sensory tests include warm and cold detection and pain thresholds, paradoxical heat sensation, mechanical detection thresholds, mechanical pain sensation and thresholds, wind up ratios, vibration thresholds and pressure pain thresholds. Clinical tests include standard neurological tests and test for heightened nerve mechanosensitivity. Blood serum to analyse inflammatory proteins. Questionnaires include neck disability index, painDETECT, PTSD8, pain catastrophising scale, eq-5D-5L, DASS 42 and global perceived recovery
Eligibility Criteria
People who have sustained a whiplash injury less than 4 weeks prior to their participation in the study. Healthy volunteers.
You may qualify if:
- Patients:
- Male and female patients with chronic whiplash associated disorder that meet the Quebec Task Force Classification of whiplash grade II
- Within approximately four weeks of their whiplash injury
- Age 18-60
- Participants capable of giving informed consent
- Healthy Volunteers:
- Free of neck or upper limb pain
- No history of a whiplash injury or of neck or arm pain lasting \>3 months or any recent cervical or upper limb trauma requiring medical treatment.
- Age 18-60
- Participants capable of giving informed consent
You may not qualify if:
- Patients:
- Diagnosis of whiplash grade I (neck complaints without physical signs), III (obvious neurological signs) or IV (fracture or dislocation)
- Experienced concussion or loss of consciousness as a result of the accident
- Previous history of whiplash
- Previous history of neck pain or headaches that required treatment
- All participants (patients and healthy volunteers):
- Unsuitability to undergo MRI (assessed with the MRI screening questionnaire)
- Pregnant
- History of inflammatory disease (e.g. autoimmune diseases, rheumatoid arthritis), neuropathy, diabetes, cancer or non-medically controlled hypertension
- Current ongoing steroid treatment
- Participants with an inadequate understanding of English will also be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sussexlead
- University of Oxfordcollaborator
Study Sites (2)
Brighton and Sussex Medical School
Brighton, East Sussex, BN1 9RY, United Kingdom
Oxford Neuroscience, University of Oxford
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Related Publications (3)
Ridehalgh C, Fundaun J, Bremner S, Cercignani M, Koushesh S, Schmid AB, Dilley A. Temporal development of peripheral neuroinflammation in whiplash-associated disorder grade II and its role in chronicity. Pain. 2026 Feb 1;167(2):356-371. doi: 10.1097/j.pain.0000000000003816. Epub 2025 Oct 10.
PMID: 41081757DERIVEDRidehalgh C, Fundaun J, Bremner S, Cercignani M, Koushesh S, Young R, Novak A, Greening J, Schmid AB, Dilley A. Evidence for peripheral neuroinflammation after acute whiplash. Pain. 2025 Oct 1;166(10):2285-2299. doi: 10.1097/j.pain.0000000000003560. Epub 2025 Mar 4.
PMID: 40035629DERIVEDRidehalgh C, Fundaun J, Bremner S, Cercignani M, Young R, Trivedy C, Novak A, Greening J, Schmid A, Dilley A. Does peripheral neuroinflammation predict chronicity following whiplash injury? Protocol for a prospective cohort study. BMJ Open. 2022 Dec 15;12(12):e066021. doi: 10.1136/bmjopen-2022-066021.
PMID: 36521884DERIVED
Biospecimen
Whole blood and serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Dilley, PhD
Brighton and Sussex Medical School
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 28, 2021
Study Start
June 1, 2021
Primary Completion
March 1, 2023
Study Completion
April 1, 2024
Last Updated
November 4, 2022
Record last verified: 2022-11